GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » Future 3-5Y EPS without NRI Growth Rate

ULIHF (United Laboratories International Holdings) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 10, 2025)


View and export this data going back to 2011. Start your Free Trial

What is United Laboratories International Holdings Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

United Laboratories International Holdings  (OTCPK:ULIHF) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

United Laboratories International Holdings Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

United Laboratories International Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (OTCPK:ULIHF) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
HKSE:02096 HKSE:00867 HKSE:00512 HKSE:03320 HKSE:06185 HKSE:01558 HKSE:00570 HKSE:02005 HKSE:01681 HKSE:02186 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
03933:Hong Kong UNJ:Germany
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
Website
http://www.tul.com.cn
United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.

United Laboratories International Holdings Headlines

No Headlines